Trial Initiated for Long-Lasting Injectable PrEP to Block HIV Transmission
HIV drug trial will evaluate cabotegravir’s performance as a pre-exposure prophylaxis.
Trial Initiated for Long-Lasting Injectable PrEP to Block HIV Transmission
Source: Virology News